Clinical trials
Completed Phase 1 trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,345 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 8 |
| 2007 | 16 |
| 2008 | 26 |
| 2009 | 44 |
| 2010 | 46 |
| 2011 | 75 |
| 2012 | 90 |
| 2013 | 94 |
| 2014 | 101 |
| 2015 | 78 |
| 2016 | 74 |
| 2017 | 84 |
| 2018 | 78 |
| 2019 | 74 |
| 2020 | 82 |
| 2021 | 100 |
| 2022 | 88 |
| 2023 | 77 |
| 2024 | 48 |
| 2025 | 44 |
| 2026 | 15 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,345 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chong Kun Dang Pharmaceutical | 147 |
| Hanmi Pharmaceutical Company Limited | 74 |
| Boryung Pharmaceutical Co., Ltd | 57 |
| Seoul National University Hospital | 53 |
| Dong-A ST Co., Ltd. | 46 |
| Yuhan Corporation | 44 |
| Daewoong Pharmaceutical Co. LTD. | 41 |
| HK inno.N Corporation | 35 |
| Boehringer Ingelheim | 28 |
| Celltrion | 25 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 81 |
| Neoplasms | 68 |
| Diabetes Mellitus, Type 2 | 65 |
| Carcinoma, Non-Small-Cell Lung | 44 |
| Dyslipidemias | 40 |
| Hyperlipidemias | 32 |
| Breast Neoplasms | 22 |
| Diabetes Mellitus | 22 |
| Essential Hypertension | 20 |
| Stomach Neoplasms | 20 |
Trials
Showing 1 to 25 of 1,345. Each trial links to its page on Pharma Observatory.
1,245 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.